🇺🇸
CAMBRIDGE, Mass., July 15, 2026 /PRNewswire/ — Decoy Therapeutics Inc. (Nasdaq: DCOY), a biotechnology company pioneering Designable Multi-Antivirals (D-MAVs™), a new category of antivirals engineered to target shared viral mechanisms, today announced that stockholders elected Patricia…
Source: prnewswire
Country: United States